Cargando…
Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury
Necroptosis contributes to the pathophysiology of several inflammatory, infectious and degenerative disorders. TNF-induced necroptosis involves activation of the receptor-interacting protein kinases 1 and 3 (RIPK1/3) in a necrosome complex, eventually leading to the phosphorylation and relocation of...
Autores principales: | Martens, Sofie, Jeong, Manhyung, Tonnus, Wulf, Feldmann, Friederike, Hofmans, Sam, Goossens, Vera, Takahashi, Nozomi, Bräsen, Jan Hinrich, Lee, Eun-Woo, Van der Veken, Pieter, Joossens, Jurgen, Augustyns, Koen, Fulda, Simone, Linkermann, Andreas, Song, Jaewhan, Vandenabeele, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520944/ https://www.ncbi.nlm.nih.gov/pubmed/28661484 http://dx.doi.org/10.1038/cddis.2017.298 |
Ejemplares similares
-
Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells
por: Feldmann, Friederike, et al.
Publicado: (2017) -
An outline of necrosome triggers
por: Vanden Berghe, Tom, et al.
Publicado: (2016) -
RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)
por: Martens, Sofie, et al.
Publicado: (2018) -
Beclin 1 functions as a negative modulator of MLKL oligomerisation by integrating into the necrosome complex
por: Seo, Jinho, et al.
Publicado: (2020) -
Nuclear RIPK3 and MLKL contribute to cytosolic necrosome formation and necroptosis
por: Weber, Kathrin, et al.
Publicado: (2018)